Revenue | ₹161.30Cr |
Net Profits | ₹11.58Cr |
Net Profit Margins | 7.18% |
Lincoln Pharmaceuticals Ltd’s revenue jumped 7.89% since last year same period to ₹161.30Cr in the Q4 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 3.72% jump in its revenue since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit fell -37.74% since last year same period to ₹11.58Cr in the Q4 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -44.25% fall in its net profits since last 3-months.
Lincoln Pharmaceuticals Ltd’s net profit margin fell -42.29% since last year same period to 7.18% in the Q4 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -46.24% fall in its net profit margins since last 3-months.
The revenue for Lincoln Pharmaceuticals Ltd in the Q4 results 2024 was ₹161.30Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q4 results 2024 was ₹11.58Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q4 results 2024 was 7.18%.
The revenue for Lincoln Pharmaceuticals Ltd in the Q4 results 2023 was ₹149.51Cr.
The net profit for Lincoln Pharmaceuticals Ltd in the Q4 results 2023 was ₹18.60Cr.
The net profit margin for Lincoln Pharmaceuticals Ltd in the Q4 results 2023 was 12.44%.